サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1439338

緑内障ドレナージデバイス - 世界市場の考察、競合情勢、市場予測（2030年）

Glaucoma Drainage Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
緑内障ドレナージデバイス - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の緑内障ドレナージデバイスの市場規模は、2023年に6億4,057万米ドル、2030年までに11億8,439万米ドルに達し、2024年～2030年の予測期間にCAGRで11.95％の成長が見込まれます。緑内障ドレナージデバイスの需要の増加は主に、世界中での緑内障の有病率の上昇、糖尿病や高血圧などの生活習慣病の増加、老年人口の負担の増大、製品開発における技術革新などに起因し、これらが緑内障ドレナージデバイス市場を押し上げると予測されます。

緑内障ドレナージデバイスの市場力学

緑内障ドレナージデバイスの需要の増加の主な要因は、世界中での緑内障の有病率の上昇です。例えば、2022年にDelhi Ophthalmological Societyが提供したデータによると、緑内障は世界中で不可逆的な失明の主因となっています。同じ資料によれば、2020年、緑内障の世界の負担は7,960万人と推定されています。また、前述の資料によると、インドは緑内障患者が2番目に多い地域になると予測されており、インドにおける緑内障患者の有病率は2020年に1,190万人になると推定されています。したがって、緑内障の有病率の増加は、予測期間（2024年～2030年）に緑内障デバイス市場を押し上げる可能性があります。

さらに、緑内障ドレナージデバイス市場の成長をもたらすもう1つの主な要因は、糖尿病と高血圧の有病率の増加である可能性があります。例えば、2023年に発表された世界保健機関（WHO）のデータによると、2020年に世界で約4億2,200万人が糖尿病を有しており、毎年約150万人が糖尿病にかかっています。このように、糖尿病は緑内障にかかる可能性を倍増させ、早期に治療しなければ視力低下や失明につながる可能性があるため、予測期間（2024年～2030年）の緑内障デバイス市場の需要を高める可能性があります。

さらに、2020年にPan American Health Organizationが発表した最新のデータによると、世界の成人人口の30％以上が高血圧症に罹患しており、世界中で10億人以上が罹患しています。また、世界保健機関が2023年に発表したデータによると、2020年、中国では約2億7,000万人が高血圧に罹患していました。さらに、高血圧によって目の動脈が損傷し、眼圧の上昇に伴う血流の変化に適応できなくなる可能性があり、緑内障の危険因子と考えられています。

今後、上記の要因が予測期間中の世界の緑内障ドレナージデバイス市場の成長に寄与します。

しかし、デバイスに関連する合併症や期間の限られた緑内障ドレナージデバイスの有効性が、緑内障ドレナージデバイス市場の成長に課題をもたらすと予測されます。

さらに、COVID-19パンデミック中、世界中で緑内障手術件数と企業の収益セグメントが大幅に減少し、緑内障ドレナージデバイス市場の成長が短期間制限されました。しかし、2020年後半にGlaukos Corporationの次世代緑内障ドレナージデバイスiStent inject Wなど複数の製品が発売されるため、緑内障ドレナージデバイス市場はパンデミック後のシナリオで世界的に回復する可能性があります。また、緑内障ドレナージデバイス市場は、より明確な予防的アプローチやガイドラインとともに、ロックダウン規制の緩和や選択的手術の再開により、再び成長する可能性があります。さらに、2020年後半に世界中で多数のCOVID-19ワクチンが承認および投与されたことにより、医療サービスを含むさまざまな領域での活動が大きく回復し、緑内障ドレナージデバイス市場の健全な回復期への道が開かれました。

緑内障ドレナージデバイス市場のセグメント分析

緑内障ドレナージデバイス市場の製品セグメントでは、低侵襲緑内障手術デバイス（MIGS）カテゴリが市場を独占すると予測され、2030年までに6億8,146万米ドルに達し、2024年～2030年の予測期間にCAGRで11.95％の成長が見込まれます。

当レポートでは、世界の緑内障ドレナージデバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 緑内障ドレナージデバイス市場レポートのイントロダクション

第2章 緑内障ドレナージデバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 緑内障ドレナージデバイス市場の主な要因の分析

  • 緑内障ドレナージデバイス市場の促進要因
    • 世界中での緑内障の有病率の上昇
    • 糖尿病や高血圧などの生活習慣病の増加
    • 増大する老年人口の負担
    • 製品開発における技術革新
  • 緑内障ドレナージデバイス市場の抑制要因と課題
    • デバイスに関連する複雑な問題
    • 期間の限られた緑内障ドレナージデバイスの有効性
  • 緑内障ドレナージデバイス市場の機会
    • MIGSデバイスの入手性の向上
    • 製品の安全性の向上

第5章 緑内障ドレナージデバイスのポーターのファイブフォース分析

第6章 緑内障ドレナージデバイス市場に対するCOVID-19の影響の分析

第7章 緑内障ドレナージデバイス市場レイアウト

  • 製品タイプ別
    • 従来式緑内障ドレナージデバイス
    • 低侵襲緑内障手術（MIGS）デバイス
  • エンドユーザー別
    • 病院
    • 外来手術センター
    • 専門クリニック
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 緑内障ドレナージデバイス：世界の企業シェア分析 - 主要3～5社

第9章 緑内障ドレナージデバイスの企業と製品のプロファイル

  • Johnson & Johnson
  • AbbVie Inc
  • Alcon Inc
  • Glaukos Corporation
  • NovaEye Medical Limited
  • iSTAR Medical SA
  • Rheon Medical SA
  • Advanced Ophthalmic Innovations Pte Ltd
  • New World Medical Inc
  • Aurolab
  • Santen Pharmaceutical Co., Ltd.

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項と連絡先

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Glaucoma Drainage Devices Market
  • Table 3: Glaucoma Drainage Devices Market Analysis in Global (2021-2030)
  • Table 4: Glaucoma Drainage Devices Market Analysis in Global by Product Type (2021-2030)
  • Table 5: Glaucoma Drainage Devices Market Analysis in Global by End User (2021-2030)
  • Table 6: Glaucoma Drainage Devices Market Analysis in Global by Geography (2021-2030)
  • Table 7: Glaucoma Drainage Devices Market Analysis in North America (2021-2030)
  • Table 8: Glaucoma Drainage Devices Market Analysis in North America by Product Type (2021-2030)
  • Table 9: Glaucoma Drainage Devices Market Analysis in North America by End User (2021-2030)
  • Table 10: Glaucoma Drainage Devices Market Analysis in North America by Country (2021-2030)
  • Table 11: Glaucoma Drainage Devices Market Analysis in the US (2021-2030)
  • Table 12: Glaucoma Drainage Devices Market Analysis in Canada (2021-2030)
  • Table 13: Glaucoma Drainage Devices Market Analysis in Mexico (2021-2030)
  • Table 14: Glaucoma Drainage Devices Market Analysis in Europe (2021-2030)
  • Table 15: Glaucoma Drainage Devices Market Analysis in Europe by Product Type (2021-2030)
  • Table 16: Glaucoma Drainage Devices Market Analysis in Europe by End User (2021-2030)
  • Table 17: Glaucoma Drainage Devices Market Analysis in Europe by Country (2021-2030)
  • Table 18: Glaucoma Drainage Devices Market Analysis in France (2021-2030)
  • Table 19: Glaucoma Drainage Devices Market Analysis in Germany (2021-2030)
  • Table 20: Glaucoma Drainage Devices Market Analysis in the UK (2021-2030)
  • Table 21: Glaucoma Drainage Devices Market Analysis in Italy (2021-2030)
  • Table 22: Glaucoma Drainage Devices Market Analysis in Spain (2021-2030)
  • Table 23: Glaucoma Drainage Devices Market Analysis in Russia (2021-2030)
  • Table 24: Glaucoma Drainage Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 25: Glaucoma Drainage Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 26: Glaucoma Drainage Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 27: Glaucoma Drainage Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 28: Glaucoma Drainage Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 29: Glaucoma Drainage Devices Market Analysis in China (2021-2030)
  • Table 30: Glaucoma Drainage Devices Market Analysis in Japan (2021-2030)
  • Table 31: Glaucoma Drainage Devices Market Analysis in India (2021-2030)
  • Table 32: Glaucoma Drainage Devices Market Analysis in Australia (2021-2030)
  • Table 33: Glaucoma Drainage Devices Market Analysis in South Korea (2021-2030)
  • Table 34: Glaucoma Drainage Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 35: Glaucoma Drainage Devices Market Analysis in Rest of World (2021-2030)
  • Table 36: Glaucoma Drainage Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 37: Glaucoma Drainage Devices Market Analysis in Rest of World by End User (2021-2030)
  • Table 38: Glaucoma Drainage Devices Market Analysis in Rest of World by Country (2021-2030)
  • Table 39: Glaucoma Drainage Devices Market Analysis in Middle East (2021-2030)
  • Table 40: Glaucoma Drainage Devices Market Analysis in Africa (2021-2030)
  • Table 41: Glaucoma Drainage Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Glaucoma Drainage Devices Market
  • Figure 3: Glaucoma Drainage Devices Market Analysis in Global (2021-2030)
  • Figure 4: Glaucoma Drainage Devices Market Analysis in Global by Product Type (2021-2030)
  • Figure 5: Glaucoma Drainage Devices Market Analysis in Global by End User (2021-2030)
  • Figure 6: Glaucoma Drainage Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 7: Glaucoma Drainage Devices Market Analysis in North America (2021-2030)
  • Figure 8: Glaucoma Drainage Devices Market Analysis in North America by Product Type (2021-2030)
  • Figure 9: Glaucoma Drainage Devices Market Analysis in North America by End User (2021-2030)
  • Figure 10: Glaucoma Drainage Devices Market Analysis in North America by Country (2021-2030)
  • Figure 11: Glaucoma Drainage Devices Market Analysis in the US (2021-2030)
  • Figure 12: Glaucoma Drainage Devices Market Analysis in Canada (2021-2030)
  • Figure 13: Glaucoma Drainage Devices Market Analysis in Mexico (2021-2030)
  • Figure 14: Glaucoma Drainage Devices Market Analysis in Europe (2021-2030)
  • Figure 15: Glaucoma Drainage Devices Market Analysis in Europe by Product Type (2021-2030)
  • Figure 16: Glaucoma Drainage Devices Market Analysis in Europe by End User (2021-2030)
  • Figure 17: Glaucoma Drainage Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 18: Glaucoma Drainage Devices Market Analysis in France (2021-2030)
  • Figure 19: Glaucoma Drainage Devices Market Analysis in Germany (2021-2030)
  • Figure 20: Glaucoma Drainage Devices Market Analysis in the UK (2021-2030)
  • Figure 21: Glaucoma Drainage Devices Market Analysis in Italy (2021-2030)
  • Figure 22: Glaucoma Drainage Devices Market Analysis in Spain (2021-2030)
  • Figure 23: Glaucoma Drainage Devices Market Analysis in Russia (2021-2030)
  • Figure 24: Glaucoma Drainage Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 25: Glaucoma Drainage Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 26: Glaucoma Drainage Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 27: Glaucoma Drainage Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 28: Glaucoma Drainage Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 29: Glaucoma Drainage Devices Market Analysis in China (2021-2030)
  • Figure 30: Glaucoma Drainage Devices Market Analysis in Japan (2021-2030)
  • Figure 31: Glaucoma Drainage Devices Market Analysis in India (2021-2030)
  • Figure 32: Glaucoma Drainage Devices Market Analysis in Australia (2021-2030)
  • Figure 33: Glaucoma Drainage Devices Market Analysis in South Korea (2021-2030)
  • Figure 34: Glaucoma Drainage Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 35: Glaucoma Drainage Devices Market Analysis in Rest of World (2021-2030)
  • Figure 36: Glaucoma Drainage Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 37: Glaucoma Drainage Devices Market Analysis in Rest of World by End User (2021-2030)
  • Figure 38: Glaucoma Drainage Devices Market Analysis in Rest of World by Country (2021-2030)
  • Figure 39: Glaucoma Drainage Devices Market Analysis in Middle East (2021-2030)
  • Figure 40: Glaucoma Drainage Devices Market Analysis in Africa (2021-2030)
  • Figure 41: Glaucoma Drainage Devices Market Analysis in South America (2021-2030)
  • Figure 42: Market Drivers
  • Figure 43: Market Barriers
  • Figure 44: Market Opportunities
  • Figure 45: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0130

Glaucoma Drainage Devices Market By Product Type (Conventional Glaucoma Drainage Devices [Valveless Glaucoma Drainage Devices And Valved Glaucoma Drainage Devices], Minimally Invasive Glaucoma Surgery (Migs) Devices [Schlemm's Canal Migs Devices, Suprachoroidal Migs Devices, And Subconjunctival Migs Devices]), By End-User (Hospitals, Ambulatory Surgical Centers, And Specialty Clinics), by geography, is anticipated to grow at a significant CAGR forecast till 2030 due to rising prevalence of glaucoma and increasing prevalence of diabetes & hypertension

The global glaucoma drainage devices market was valued at USD 640.57 million in 2023, growing at a CAGR of 11.95% during the forecast period from 2024 to 2030, to reach USD 1,184.39 million by 2030. The increase in demand for glaucoma drainage devices is primarily due to the rising prevalence of glaucoma across the globe, increasing lifestyle disorders such as diabetes & hypertension, the growing burden of the old age population, and technical innovation in product development are expected to boost the market for glaucoma drainage devices.

Glaucoma Drainage Devices Market Dynamics:

The key factor responsible for the increasing demand for glaucoma drainage devices is the rising prevalence of glaucoma conditions worldwide. For instance, as per the data provided by the Delhi Ophthalmological Society in 2022, glaucoma is the leading cause of irreversible blindness across the world. As per the same source, in 2020, the global burden of glaucoma was estimated to be 79.6 million. Also, according to the aforementioned source, India is expected to be the second-largest home of glaucoma patients, and the estimated prevalence of glaucoma cases in India was estimated to be 11.9 million in 2020. Therefore, the increasing prevalence of glaucoma could boost the glaucoma devices market during the forecast period (2024-2030).

Further, another key factor that is responsible for the growth of the glaucoma drainage devices market could be the increasing prevalence of diabetes & hypertension. For instance, as per the World Health Organization data published in the year 2023, in 2020, about 422 million people worldwide had diabetes, and about 1.5 million people suffer from diabetes every year. Thus, diabetes doubles the chances of having glaucoma, which can lead to vision loss and blindness if not treated early, which can increase the glaucoma devices market demand during the forecast period (2024-2030).

Furthermore, according to the latest data published by Pan American Health Organization in 2020, hypertension had affected more than 30% of the adult population worldwide, accounting for more than one billion people around the world. Also, as per the data published by World Health Organization in the year 2023, in 2020, about 270 million people were affected by hypertension in China. Moreover, the blood arteries in the eyes may be damaged by hypertension and unable to adjust to changes in blood flow as a result of rising ocular pressure, which is considered to be a risk factor for glaucoma.

Henceforth, the above-mentioned factors will contribute to the global glaucoma drainage devices market growth during the forecasted period.

However, complications associated with the devices and efficacy of glaucoma drainage devices for a limited timeframe are expected to pose a challenge to the glaucoma drainage devices market growth.

Additionally, there was a significant reduction in the glaucoma surgical volume procedures and company revenue segments across the globe during the COVID-19 pandemic, which restricted the glaucoma-drainage device market growth for a brief period. However, due to the launch of several products such as the iStent inject W by Glaukos Corporation, a next-generation glaucoma drainage device, in the second half of 2020, the glaucoma drainage devices market potentially redeem itself across the globe in the post-pandemic scenario. Also, the easing of lockdown restrictions and resumed elective surgeries along with more clear precautionary approaches and guidelines lead to the renewed market growth of glaucoma drainage devices. Moreover, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains, including healthcare services, thereby paving the way for a sound period of recovery for the glaucoma drainage devices market.

Glaucoma Drainage Devices Market Segment Analysis:

Glaucoma Drainage Devices Market By Product Type (Conventional Glaucoma Drainage Devices [Valveless Glaucoma Drainage Devices and Valved Glaucoma Drainage Devices], Minimally Invasive Glaucoma Surgery (MIGS) Devices [Schlemm's Canal MIGS Devices, Suprachoroidal MIGS Devices, and Subconjunctival MIGS Devices]), End-User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the glaucoma drainage devices market, the Minimally Invasive Glaucoma Surgery devices (MIGS) category is expected to dominate the market and is estimated to grow at a CAGR of 11.95% during the forecast period from 2024-2030 to reach USD 681.46 million by 2030. The MIGS devices are categorized into Schlemm's Canal MIGS Devices, Suprachoroidal MIGS Devices, and Subconjunctival MIGS Devices. Schlemm's canal MIGS devices are used to increase trabecular outflow by bypassing the trabecular meshwork and directing aqueous humor into Schlemm's canal. Since the trabecular meshwork is considered the primary site of resistance to aqueous humor outflow, bypassing this structure and directing aqueous flow from the anterior chamber directly into Schlemm's canal seemed to be a reasonable approach that increases the demand for these devices.

Moreover, as per the various studies, the Intraocular Pressure (IOP)-lowering efficacy of subconjunctival MIGS appears to approach that of traditional filtering surgery, thereby offering the possibility that they might have utility in more advanced or normal-pressure glaucoma. Further, recently, in May 2022, PRESSERFLO, subconjunctival MIGS devices, was approved by Health Canada to reduce in patients with primary open-angle glaucoma (POAG) whose IOP is not controlled when using maximum tolerated glaucoma medications

Hence, all the aforementioned factors will lead to the segmental growth of the glaucoma drainage devices market in the coming years.

North America is expected to dominate the overall Glaucoma Drainage Devices Market:

Among all the regions, North America dominated the market in the year 2023 and is estimated to grow at a CAGR of 11.06% during the forecast period from 2024 to 2030 to reach USD 453.39 million by 2030. This domination can be primarily attributed to the rising cases of lifestyle-related disorders such as diabetes and the rising geriatric population.

For instance, as per the National Diabetics Statistics Report published by the Centers for Disease Control and Prevention (CDC) in the year 2020, about 34.2 million Americans had diabetes 2020. The report further stated that approximately 88 million Americans showed pre-diabetes levels. The CDC considers diabetes to be one of the major risk factors that may lead to glaucoma development. Thus, diabetes doubles the chances of having glaucoma, which can lead to vision loss and blindness if not treated early, which can increase the glaucoma devices market demand during the forecast period (2024-2030).

According to the data published by the World Bank Group in the year 2023, approximately 9,822,231 population in Mexico were aged 65 years and above in 2020. Thus, the geriatric population is more susceptible to developing glaucoma is also expected to raise the demand for glaucoma drainage devices in the upcoming years.

The market presence of key manufacturers such as Johnson & Johnson, Allergan, and others active in manufacturing glaucoma drainage devices will also contribute to the market growth of these devices.

Thus, all the above-mentioned factors are projected to surge the market for glaucoma drainage devices in the region.

Glaucoma Drainage Devices Market Key Players:

Some of the key market players operating in the glaucoma drainage devices market include Johnson & Johnson, AbbVie Inc, Alcon Inc, Glaukos Corporation, Santen Pharmaceutical Co., Ltd, NovaEye Medical Limited, iSTAR Medical SA, Rheon Medical SA, Advanced Ophthalmic Innovations Pte Ltd, New World Medical Inc, Aurolab, and others.

Recent Developmental Activities in the Glaucoma Drainage Devices Market:

In October 2022, Alcon, the world leader in eye care committed to enabling people to see brilliantly, announced the completion of its previously announced acquisition of Ivantis®, maker of the ground-breaking Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) tool intended to reduce eye pressure for open-angle glaucoma patients in conjunction with cataract surgery.

In November 2022, iSTAR Medical a MedTech company committed to delivering breakthrough eye care solutions through minimally-invasive implants designed for bio-integration, received European market approval for glaucoma implant MINIject designed to significantly reduce IOP by enhancing aqueous humor outflow from the anterior chamber to the suprachoroidal space.

In May 2022, Santen Canada Inc., a subsidiary of Santen Pharmaceutical Co., a global company focused on developing ophthalmology products, received Health Canada approval for PRESERFLOTM MicroShunt. This surgical device helps drain eye fluid and reduce intraocular pressure (IOP) in patients with POAG.

Key Takeaways from the Glaucoma Drainage Devices Market Report Study:

  • Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the glaucoma drainage devices market.
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the global glaucoma drainage devices market.
  • Various opportunities are available for the other competitor in the glaucoma drainage devices market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current glaucoma drainage devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for glaucoma drainage devices market growth in the coming future?

Target Audience who can be benefited from the Glaucoma Drainage Devices Market Report Study

  • Glaucoma drainage devices providers
  • Research organizations and consulting companies
  • Wound closure devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in glaucoma drainage devices
  • Various end-users want to know more about the glaucoma drainage devices market and the latest technological developments in the glaucoma drainage devices market.

Frequently Asked Questions for the Glaucoma Drainage Devices Market:

1. What are Glaucoma Drainage Devices?

Glaucoma drainage devices have been designed to divert the aqueous humor from the anterior chamber to the external reservoir. A fibrous capsule is formed in about 4-6 weeks after the surgery and regulates the flow. The devices are extensively used in complicated glaucoma, comprising uveitic glaucoma, neovascular glaucoma, and pediatric and developmental glaucoma.

2. What is the market for Global Glaucoma Drainage Devices?

The global glaucoma drainage devices market was valued at USD 640.57 million in 2023, growing at a CAGR of 11.95% during the forecast period from 2024 to 2030, to reach USD 1,184.39 million by 2030.

3. What are the drivers for the Global Glaucoma Drainage Devices?

The major factors driving the demand for glaucoma drainage devices are the rising prevalence of glaucoma across the globe, increasing lifestyle disorders such as diabetes & hypertension, the growing burden of the old age population, and technical innovation in product development.

4. What are the key players operating in Global Glaucoma Drainage Devices?

Some of the key market players operating in the glaucoma drainage devices market include Johnson & Johnson, AbbVie Inc, Alcon Inc, Glaukos Corporation, Santen Pharmaceutical Co., Ltd, NovaEye Medical Limited, iSTAR Medical SA, Rheon Medical SA, Advanced Ophthalmic Innovations Pte Ltd, New World Medical Inc, Aurolab, and others.

5. Which region has the highest share in the Glaucoma Drainage Devices Market?

Among all the regions, North America is expected to occupy a major share in the overall glaucoma drainage devices market during the forecasted years, 2024-2030. This domination can be primarily attributed to the rising cases of lifestyle-related disorders such as diabetes and the rising geriatric population.

Table of Contents

1.Glaucoma Drainage Devices Market Report Introduction

2. Glaucoma Drainage Devices Market Executive summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Glaucoma Drainage Devices Market Key factors analysis

  • 4.1. Glaucoma Drainage Devices Market Drivers
    • 4.1.1. The Rising Prevalence of Glaucoma Across the Globe
    • 4.1.2. Increasing Lifestyle Disorders such as Diabetes & Hypertension
    • 4.1.3. Growing Burden of Old Age Population
    • 4.1.4. Technical Innovation in Product Development
  • 4.2. Glaucoma Drainage Devices Market Restraints and Challenges
    • 4.2.1. Complications Associated with the Devices
    • 4.2.2. Efficacy of Glaucoma Drainage Devices For Limited Timeframe
  • 4.3. Glaucoma Drainage Devices Market Opportunities
    • 4.3.1. Improving the Affordability of MIGS Devices
    • 4.3.2. Improving on Product Safety

5. Glaucoma Drainage Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Glaucoma Drainage Devices Market

7. Glaucoma Drainage Devices Market layout

  • 7.1. By Product Type
    • 7.1.1. Conventional Glaucoma Drainage Devices
      • 7.1.1.1. Valveless Glaucoma Drainage Devices
      • 7.1.1.2. Valved Glaucoma Drainage Devices
    • 7.1.2. Minimally Invasive Glaucoma Surgery (MIGS) Devices
      • 7.1.2.1. Schlemm's Canal MIGS Devices
      • 7.1.2.2. Suprachoroidal MIGS Devices
      • 7.1.2.3. Subconjunctival MIGS Devices
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
    • 7.2.3. Specialty Clinics
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. North America Glaucoma Drainage Devices Market in USD Million, by Product Type (2021-2030)
      • 7.3.1.2. North America Glaucoma Drainage Devices Market in USD Million, by End-User (2021-2030)
      • 7.3.1.3. North America Glaucoma Drainage Devices Market in USD Million, by Country (2021-2030)
      • 7.3.1.3.1. United States Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.1.3.2. Canada Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.1.3.3. Mexico Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. Europe Glaucoma Drainage Devices Market in USD Million, by Product Type (2021-2030)
      • 7.3.2.2. Europe Glaucoma Drainage Devices Market in USD Million, by End-User (2021-2030)
      • 7.3.2.3. Europe Glaucoma Drainage Devices Market in USD Million, by Country (2021-2030)
      • 7.3.2.3.1. France Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.2.3.2. Germany Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.2.3.3. United Kingdom Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.2.3.4. Italy Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.2.3.5. Spain Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.2.3.6. Russia Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.2.3.7. Rest of Europe Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. Asia-Pacific Glaucoma Drainage Devices Market in USD Million, by Product Type (2021-2030)
      • 7.3.3.2. Asia-Pacific Glaucoma Drainage Devices Market in USD Million, by End-User (2021-2030)
      • 7.3.3.3. Asia-Pacific Glaucoma Drainage Devices Market in USD Million, by Country (2021-2030)
      • 7.3.3.3.1. China Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.3.3.2. Japan Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.3.3.3. India Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.3.3.4. Australia Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.3.3.5. South Korea Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.3.3.6. Rest of Asia Pacific Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. RoW Glaucoma Drainage Devices Market in USD Million, by Product Type (2021-2030)
      • 7.3.4.2. RoW Glaucoma Drainage Devices Market in USD Million, by End-User (2021-2030)
      • 7.3.4.3. RoW Glaucoma Drainage Devices Market in USD Million, by Region (2021-2030)
      • 7.3.4.3.1. Middle East Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.4.3.2. Africa Glaucoma Drainage Devices Market Size in USD Million (2021-2030)
      • 7.3.4.3.3. South America Glaucoma Drainage Devices Market Size in USD Million (2021-2030)

8. Glaucoma Drainage Devices Global Company Share Analysis - Key 3-5 Companies

9. Glaucoma Drainage Devices Company and Product Profiles

  • 9.1. Johnson & Johnson
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. AbbVie Inc
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Alcon Inc
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Glaukos Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. NovaEye Medical Limited
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. iSTAR Medical SA
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Rheon Medical SA
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Advanced Ophthalmic Innovations Pte Ltd
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. New World Medical Inc
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Aurolab
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Santen Pharmaceutical Co., Ltd.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us